Applications of the GOAL study in childhood asthma
Implicaciones del estudio GOAL en el asma infantil
Read
11270
Timeswas read the article
2588
Total PDF
8682
Total HTML
Share statistics
array:20 [ "pii" => "13075543" "issn" => "16954033" "doi" => "10.1157/13075542" "estado" => "S300" "fechaPublicacion" => "2005-06-01" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2005;62:519-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 6774 "formatos" => array:3 [ "EPUB" => 89 "HTML" => 6092 "PDF" => 593 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "13075542" "issn" => "16954033" "doi" => "10.1157/13075542" "estado" => "S300" "fechaPublicacion" => "2005-06-01" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2005;62:519-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 7545 "formatos" => array:3 [ "EPUB" => 85 "HTML" => 6711 "PDF" => 749 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Implicaciones del estudio GOAL en el asma infantil" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "519" "paginaFinal" => "521" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Applications of the GOAL study in childhood asthma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "JA Castro-Rodríguez" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "JA" "apellidos" => "Castro-Rodríguez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "13075543" "doi" => "10.1157/13075542" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13075543?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13075542?idApp=UINPBA00005H" "url" => "/16954033/0000006200000006/v0_201404151204/13075542/v0_201404151204/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "13075542" "issn" => "16954033" "doi" => "10.1157/13075542" "estado" => "S300" "fechaPublicacion" => "2005-06-01" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2005;62:519-21" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 7545 "formatos" => array:3 [ "EPUB" => 85 "HTML" => 6711 "PDF" => 749 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Implicaciones del estudio GOAL en el asma infantil" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "519" "paginaFinal" => "521" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Applications of the GOAL study in childhood asthma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "JA Castro-Rodríguez" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "JA" "apellidos" => "Castro-Rodríguez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "13075543" "doi" => "10.1157/13075542" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13075543?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13075542?idApp=UINPBA00005H" "url" => "/16954033/0000006200000006/v0_201404151204/13075542/v0_201404151204/es/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Applications of the GOAL study in childhood asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "519" "paginaFinal" => "521" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "JA Castro-Rodríguez" "autores" => array:1 [ 0 => array:3 [ "Iniciales" => "JA" "apellidos" => "Castro-Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Departamento de Medicina Respiratoria Infantil. Facultad de Ciencias Médicas.Universidad de Santiago de Chile. Chile." "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Implicaciones del estudio GOAL en el asma infantil" ] ] "textoCompleto" => "<p class="elsevierStylePara">Considering recent epidemiologic data we find strong evidence suggesting the advantage of starting the asthma therapy with controllers or preventive drugs very early on life, better in the first 5 years of age. The epidemiologic studies supporting that idea are: first able around 80 % of asthmatics start their disease in the first 12 years of age <span class="elsevierStyleSup">1</span>, second the cohort study from Melbourne <span class="elsevierStyleSup">2</span> shows that asthma is a "tracking disease" in symptoms and pulmonary function, meaning that a person that as a child have certain severity of disease and pulmonary function compromised will have the same compromise when he or she become an adult and third the cohort study from Tucson <span class="elsevierStyleSup">3</span> demonstrates that the asthmatic suffer the major loosing in pulmonary function in the first 5 years of age.</p><p class="elsevierStylePara">Besides those epidemiologic data, studies in asthmatic children where bronchoalverolar lavage were done demonstrated the presence of inflammation in the air way in children 8 years old <span class="elsevierStyleSup">4</span> and even in infants as little as 15 months of age with persistent wheezing <span class="elsevierStyleSup">5</span>. There are also studies which demonstrate airway remodeling in asthmatic children <span class="elsevierStyleSup">6-7</span> and the most amazing finding is the fact of the thickness of the basal membrane of the airway in asthmatic children without controlled of their disease is very similar to severe asthmatic adults and it is not related either with the duration of the disease <span class="elsevierStyleSup">8</span>. Therefore, we end up once more to the same conclusion that is essential to start the treatment of asthma with controllers or preventing drugs at infancy.</p><p class="elsevierStylePara">The only drugs which have been demonstrated to be useful to stop the airway remodeling in humans are the inhaled corticosteroids (ICS) like beclomethasone <span class="elsevierStyleSup">9</span>, budesonide <span class="elsevierStyleSup">10</span> and fluticasone <span class="elsevierStyleSup"> 11</span> and the long active beta agonists like salmeterol <span class="elsevierStyleSup"> 12</span>. The ICS that needs lower doses and less time to decrease the thickness of the basal membrane of the airway in asthmatics was fluticasone <span class="elsevierStyleSup">11</span>. There is no evidence in the scientific literature that other type of drugs use for asthma like chromones, theophyllines or leukotriene receptor antagonists have any effect in stopping the airway remodeling in humans. These anti-inflammatory and anti-remodeling effects that the ICS has demonstrated besides their already well know utility in improving symptoms and pulmonary function <span class="elsevierStyleSup">13</span> make ICS become the first controller drug in asthma. This should be use very early on life (in the first 5 years) otherwise the results will not be satisfactory, like Childhood Asthma Management Program (CAMP) study <span class="elsevierStyleSup">14</span> demonstrated. In that study the children did not improve their pulmonary function maybe because the ICS treatment started after that age.</p><p class="elsevierStylePara">The problem is that in the first 5 years of age coexisting at least three phenotypes of wheezing in children (transitory, late and persistent or classic asthmatic). One way to differentiate which infant with recurrent wheezing will become asthmatic in order to early start ICS therapy is using the asthma predictive value (API) <span class="elsevierStyleSup">15</span>. Those infants with recurrent wheezing in the Tucson cohort who had a positive API had 7 times more risk to become asthmatic at school age. In other words, if an infant with recurrent wheezing come to the office and we apply the API and the result is positive we can tell the mother with 77 % of certain that the infant will became asthmatic at school age and start controller drugs will be more effective. In the other hand, if the API is negative we can tell the mother with 70 % of certain that the child will stop wheezing when he or she reaches school age.</p><p class="elsevierStylePara">All of us who are involve in asthma management try to have our asthmatic children free of exacerbations, emergency consults, symptoms with exercise, improved their pulmonary function and quality of life, in other words, stop feeling asthmatic or have a normal life. However, epidemiologic questionnaires done in several parts of the world <span class="elsevierStyleSup">16-18</span> have shown that around 95 % of the asthmatic do not reach the control of their disease according to international guidelines <span class="elsevierStyleSup">19,20</span>.</p><p class="elsevierStylePara">One of the more remarkable issues is that most of the clinical trials done to investigate the efficacy of different drugs in asthma consider as the outcome only one parameter (either clinical, laboratory or pulmonary function) and therefore, besides overestimating the level of asthma control <span class="elsevierStyleSup">21</span>. They do not consider that an asthmatic patient like other chronic patient need to be controlled in not only one parameter but also in a group of several parameters.</p><p class="elsevierStylePara">Few months ago, Bateman et al <span class="elsevierStyleSup">22</span> published the results of the GOAL study <span class="elsevierStyleItalic">(The Gaining Optimal Asthma Control Study)</span>. GOAL was a 1-year, stratified, randomized, double-blind, parallel-group study comparing the efficacy and safety of individual, predefined, stepwise increases of salmeterol/fluticasone with fluticasone alone in achieving two predefined composite measures of asthma control ("well control" and "total control"). Those outcomes are new and involve many clinical and pulmonary functions criteria as a whole.</p><p class="elsevierStylePara">The GOAL <span class="elsevierStyleSup"> 22</span> study defined that a patient reaches "total control" of asthma if in 7 out of 8 weeks fulfills all of the following criteria: without symptoms in the day, no rescue medication use, normal pulmonary function (peak expiratory flow [PEF] am > 80 %), no wake-ups at night, no exacerbations, no emergency visits and without secondary effects. We can say that "total control" means clinical remission of asthma and that objective was more stringent than the one that Global Iniciative for Asthma (GINA) <span class="elsevierStyleSup">19</span> proposed. The "well control" was defined as the fact that in 7 out of 8 weeks the patient fulfills the criteria: no wake-ups at night, no exacerbations, no emergency visits and no secondary effects <span class="elsevierStyleItalic">PLUS</span> at least more than two of the follows criteria: ≤ 2 days with light symptoms, use of rescue medications in ≤ 2 days and ≤ 4 times/week and normal pulmonary function (PEF am > 80 %).</p><p class="elsevierStylePara">From a total of 5068 patients (between 12 and 80 years of age) recruited in 44 countries, 3421 patients fulfilled the inclusion criteria. Interesting 10 % of them were adolescents (12-17 years-old). At the beginning of the study the patients were separate in three strata- according to the ICS uses- and were randomized to received salmeterol/fluticasone or fluticasone alone. In each strata, the percentage of patients who reached the "well control" and the "total control" definition were statistical more frequent in the salmeterol/fluticasone group vs. fluticasone. And at the end of the year considerable proportion of patients (41 %; all strata) in the salmeterol/fluticasone group reach the "total control". Moreover, those patient in the salmeterol/fluticasone group reach the "total control" with 60 % less dose of ICS and earlier than those in the fluticasone group. In the other hand, the patients in the salmeterol/ fluticasone group had better quality of life - according to Asthma Quality of Life Questionnaire (AQLQ) scale- than those in the fluticasone group and without differences in adverse events. This study demonstrated, for the first time, the fact that "total control" in asthma can be reach and that is a challenge that physicians and patients have to struggle for.</p><p class="elsevierStylePara">According to the evidence mentioned at the beginning of this editorial, the main question in pediatrics is if the GOAL results can be apply to asthmatic children under 12 years of age. Unfortunately, there is no clinical trial done for that age with the same design, however institutions like NAEPP <span class="elsevierStyleSup">23</span> in the US and in the British Thoracic Society in UK have has in their guidelines the uses of ICS plus long active beta agonist for asthmatic children under 5 years of age with moderate to severe persistent asthma.</p><p class="elsevierStylePara">Moreover, there are some clinical trials which proved the efficacy of salmeterol/fluticasone in asthmatic children less than 12 years of age. For example, Van der Berg et al <span class="elsevierStyleSup">24</span> in a multicenter, randomized, double blind and parallel-group study compared the clinical efficacy of salmeterol (50 μg bid) plus fluticasone (100 μg bid) administrated in one single inhaler (combination therapy with Accuhaler ®) vs. concurrently in two separate Accuhaler ® inhalers. From a total of 257 asthmatic children (aged 4-11 years) who remained symptomatic on ICS alone (200-500 μg beclomenthasone or budesonide) were randomized to one of each group. After 12 weeks of treatment both groups of children (combination and separate therapy) were similar in improve PEF, clinical score, less use of rescue drugs, well tolerate therapy and few secondary effects. Bracamonte et al <span class="elsevierStyleSup"> 25</span> in a multicenter, randomized study compared 428 asthmatic children (4-11 years) who remained symptomatic on moderate doses of ICS (≤ 500 μg beclomethasone or budesonide). One group received salmeterol/fluticasone in a MDI free of CFC (25/50 μg two inhalations bid) and the other salmeterol/fluticasone in Accuhaler ® device (50/100 μg one inhalation bid) for 12 weeks. Clinical improve was reached in 90 % and 86 % of the children in each group, respectively. Finally, Sekhsaria S. et al <span class="elsevierStyleSup">26</span> in a retrospective study with 50 children (5-60 months of age) with recurrent wheezing demonstrated clinical improve (decrease emergency visits, hospitalization and exacerbations) when they started the treatment with salmeterol/fluticasone.</p><p class="elsevierStylePara">Even though these clinical trials with salmeterol/fluticasone in children under 12 years of age are not big in number of children enrolled and have different design to the GOAL study, their results are promising.</p><p class="elsevierStylePara"><span class="elsevierStyleBold"> Competing interest statement</span></p><p class="elsevierStylePara">JACR: in the past five years has been received reimbursement for attending conferences from Grünenthal, Merck, GlaxoSmithKline and Andromaco, at the present he is medical advisor for GSK. The position of this paper is a personal opinion and does not express the opinion of any pharmaceutical company</p>" "pdfFichero" => "37v62n06a13075543pdf001.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "A community-based study of the epidemiology of asthma. Incidence rates 1964:1983." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Yunginger JW" 1 => "Reed CE" 2 => "O'Connell EJ" 3 => "Melton LJ" 4 => "O'Fallon WM" 5 => "Silverstein MD." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm/146.4.888" "Revista" => array:6 [ "tituloSerie" => "Am Rev Resp Dis" "fecha" => "1992" "volumen" => "146" "paginaInicial" => "888" "paginaFinal" => "94" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1416415" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The Melbourne Asthma Study: 1964-99." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Phelan PD" 1 => "Robertson CF" 2 => "Olinsky A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2002" "volumen" => "109" "paginaInicial" => "189" "paginaFinal" => "94" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11842286" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Tucson Children's Respiratory Study: 1980 to present." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Taussing LM" 1 => "Wright AL" 2 => "Holberg CJ" 3 => "Halonen M" 4 => "Morgan WJ" 5 => "Martinez FD." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2003" "volumen" => "111" "paginaInicial" => "661" "paginaFinal" => "75" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12704342" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Bronchoalveolar lavage findings suggest two different forms of childhood asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Stevenson EC" 1 => "Turner G" 2 => "Heaney LG" 3 => "Schock BC" 4 => "Taylor R" 5 => "Gallagher T" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Exp Allergy" "fecha" => "1997" "volumen" => "27" "paginaInicial" => "1027" "paginaFinal" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9678834" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Persistent wheezing in very young children is associated with lower respiratory inflammation." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Krawiec ME" 1 => "Westcott JY" 2 => "Chu HW" 3 => "Balzar S" 4 => "Trudeau JB" 5 => "Schwartz LB" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.163.6.2005116" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2001" "volumen" => "163" "paginaInicial" => "1338" "paginaFinal" => "43" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11371398" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Resp J. 1997;10 Suppl 25:160." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Resp J. 1997;10 Suppl 25:160." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Pohunek P" 1 => "Roche WR" 2 => "Turzikova J" 3 => "Kudrmann J" 4 => "Warner JO." ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Cokugras H" 1 => "Akcakaya N" 2 => "Seckin C" 3 => "Camcioglu Y" 4 => "Sarimurat N" 5 => "Aksoy F." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2001" "volumen" => "56" "paginaInicial" => "25" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11120900" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Early thinckening of the reticular basement membrane in children with difficult asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Payne DN" 1 => "Rogers AV" 2 => "Adelroth E" 3 => "Bandi V" 4 => "Guntupalli KK" 5 => "Bush A" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200205-414OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2003" "volumen" => "167" "paginaInicial" => "78" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12502479" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Hoshino M" 1 => "Takahashi M" 2 => "Takai Y" 3 => "Jae-Joon S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "1999" "volumen" => "104" "paginaInicial" => "356" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10452757" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled sterid." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Laitinen A" 1 => "Altraja A" 2 => "Kampe M" 3 => "Linden M" 4 => "Virtanen I" 5 => "Laitinen L." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.156.3.9610084" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "1997" "volumen" => "156" "paginaInicial" => "951" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9310019" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Olivieri D" 1 => "Chetta A" 2 => "Del Donno M" 3 => "Bertorelli G" 4 => "Casalini A" 5 => "Pesci A" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.155.6.9196087" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "1997" "volumen" => "155" "paginaInicial" => "1864" "paginaFinal" => "71" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9196087" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Effect of a long-acting b2 agonist over three months on airway wall vascular remodeling in asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Orsida BE" 1 => "Ward C" 2 => "Li X" 3 => "Bish R" 4 => "Wilson JW" 5 => "Thien F" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.164.1.2006003" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2001" "volumen" => "164" "paginaInicial" => "117" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11435249" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Agertoft L" 1 => "Pedersen S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Resp Med" "fecha" => "1994" "volumen" => "88" "paginaInicial" => "373" "paginaFinal" => "81" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Long-term effects of budesonide or nedocromil in children with asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "CAMP Research Group." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200010123431501" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "343" "paginaInicial" => "1054" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11027739" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "A clinical index to define risk of asthma in young children with recurrent wheezing." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Castro-Rodriguez JA" 1 => "Wright AL" 2 => "Taussig LM" 3 => "Martinez FD." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.162.4.9912111" "Revista" => array:6 [ "tituloSerie" => "Am J Resp Crit Care Med" "fecha" => "2000" "volumen" => "162" "paginaInicial" => "1403" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11029352" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Inadequate use of asthma medication in the United States: Results of the asthma in America national population survey." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Adams RJ" 1 => "Fuhlbrigge A" 2 => "Guilbert T" 3 => "Lozano P" 4 => "Martinez F." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2002" "volumen" => "110" "paginaInicial" => "58" "paginaFinal" => "64" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12110821" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Rabe KF" 1 => "Vermeire PA" 2 => "Soriano JB" 3 => "Maier WC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2000" "volumen" => "16" "paginaInicial" => "802" "paginaFinal" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11153575" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma control in the Asia-Pacific region: The Asthma Insights and Reality in Asia-Pacific Study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Lai CK" 1 => "De Guia TS" 2 => "Kim YY" 3 => "Kuo SH" 4 => "Mukhopadhyay A" 5 => "Soriano JB" 6 => "et al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/mai.2003.30" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2003" "volumen" => "111" "paginaInicial" => "263" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12589343" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Global strategy for asthma management and prevention. NIH; 2002. Publication No. 02-3659." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Global strategy for asthma management and prevention. NIH; 2002. Publication No. 02-3659." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Global Initiative for Asthma (GINA)." ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "British guideline on the management of asthma. Thorax 2003;58 Suppl I:1-94." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "British guideline on the management of asthma. Thorax 2003;58 Suppl I:1-94." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "British Thoracic Society/Scottish Intercollegiate Guidelines Network." ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Is overall asthma control being achieved? A hypothesis-generating study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Bateman ED" 1 => "Bousquet J" 2 => "Braunstein GL." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2001" "volumen" => "17" "paginaInicial" => "589" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11401050" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170: 836-44. Epub 2004 Jul 15." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170: 836-44. Epub 2004 Jul 15." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Bateman ED" 1 => "Boushey HA" 2 => "Bousquet J" 3 => "Busse WW" 4 => "Clark TJ" 5 => "Pauwels RA" 6 => "et al; GOAL Investigators Group." ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "referenciaCompleta" => "Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002, (Publication 02-5075). National Institutes of Health: Bethesda; 2002." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002, (Publication 02-5075). National Institutes of Health: Bethesda; 2002." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "National Asthma Education and Prevention Program." ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Salmeterol/fluticasone propionate (50/100 mg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Van den Berg NJ" 1 => "Ossip MS" 2 => "Hederos CA" 3 => "Anttila H" 4 => "Ribeiro BL" 5 => "Davies PI." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatr Pulmonol" "fecha" => "2000" "volumen" => "30" "paginaInicial" => "97" "paginaFinal" => "105" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10922131" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskus or Pressurised Metered-Dose Inhaler in Children with Asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Bracamonte T" 1 => "Schauer U" 2 => "Emeryk A" 3 => "Godwood A" 4 => "Balsara S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Drug Invest" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "1" "paginaFinal" => "11" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Efficacy and safety of inhaled corticosteroids in combination with a long-acting b2-agonist in asthmatic children under age 5." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Sekhsaria S" 1 => "Alam M" 2 => "Sait T" 3 => "Starr B" 4 => "Parekh M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Asthma" "fecha" => "2004" "volumen" => "41" "paginaInicial" => "575" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15360067" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16954033/0000006200000006/v0_201404151204/13075543/v0_201404151204/en/main.assets" "Apartado" => array:4 [ "identificador" => "14281" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/16954033/0000006200000006/v0_201404151204/13075543/v0_201404151204/en/37v62n06a13075543pdf001.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13075543?idApp=UINPBA00005H" ]
Article information
ISSN: 16954033Original language: English
DOI:10.1157/13075542
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 9 | 12 | 21 |
| 2024 October | 68 | 44 | 112 |
| 2024 September | 68 | 35 | 103 |
| 2024 August | 107 | 65 | 172 |
| 2024 July | 56 | 35 | 91 |
| 2024 June | 66 | 30 | 96 |
| 2024 May | 66 | 36 | 102 |
| 2024 April | 64 | 31 | 95 |
| 2024 March | 50 | 45 | 95 |
| 2024 February | 67 | 41 | 108 |
| 2024 January | 42 | 27 | 69 |
| 2023 December | 30 | 15 | 45 |
| 2023 November | 66 | 28 | 94 |
| 2023 October | 54 | 30 | 84 |
| 2023 September | 39 | 23 | 62 |
| 2023 August | 44 | 25 | 69 |
| 2023 July | 42 | 31 | 73 |
| 2023 June | 56 | 30 | 86 |
| 2023 May | 51 | 24 | 75 |
| 2023 April | 27 | 24 | 51 |
| 2023 March | 46 | 28 | 74 |
| 2023 February | 27 | 26 | 53 |
| 2023 January | 33 | 27 | 60 |
| 2022 December | 47 | 17 | 64 |
| 2022 November | 47 | 43 | 90 |
| 2022 October | 68 | 61 | 129 |
| 2022 September | 39 | 44 | 83 |
| 2022 August | 62 | 68 | 130 |
| 2022 July | 44 | 47 | 91 |
| 2022 June | 40 | 50 | 90 |
| 2022 May | 45 | 43 | 88 |
| 2022 April | 51 | 51 | 102 |
| 2022 March | 45 | 77 | 122 |
| 2022 February | 38 | 81 | 119 |
| 2022 January | 53 | 54 | 107 |
| 2021 December | 43 | 51 | 94 |
| 2021 November | 44 | 61 | 105 |
| 2021 October | 57 | 62 | 119 |
| 2021 September | 39 | 58 | 97 |
| 2021 August | 32 | 38 | 70 |
| 2021 July | 25 | 36 | 61 |
| 2021 June | 31 | 46 | 77 |
| 2021 May | 52 | 44 | 96 |
| 2021 April | 95 | 63 | 158 |
| 2021 March | 72 | 25 | 97 |
| 2021 February | 73 | 19 | 92 |
| 2021 January | 51 | 15 | 66 |
| 2020 December | 32 | 12 | 44 |
| 2020 November | 21 | 7 | 28 |
| 2020 October | 14 | 13 | 27 |
| 2020 September | 15 | 15 | 30 |
| 2020 August | 20 | 18 | 38 |
| 2020 July | 20 | 14 | 34 |
| 2020 June | 20 | 14 | 34 |
| 2020 May | 36 | 14 | 50 |
| 2020 April | 14 | 7 | 21 |
| 2020 March | 20 | 12 | 32 |
| 2020 February | 28 | 11 | 39 |
| 2020 January | 28 | 6 | 34 |
| 2019 December | 40 | 16 | 56 |
| 2019 November | 23 | 7 | 30 |
| 2019 October | 19 | 15 | 34 |
| 2019 September | 20 | 13 | 33 |
| 2019 August | 26 | 17 | 43 |
| 2019 July | 18 | 16 | 34 |
| 2019 June | 42 | 13 | 55 |
| 2019 May | 39 | 35 | 74 |
| 2019 April | 36 | 19 | 55 |
| 2019 March | 21 | 16 | 37 |
| 2019 February | 31 | 9 | 40 |
| 2019 January | 24 | 19 | 43 |
| 2018 December | 27 | 19 | 46 |
| 2018 November | 43 | 27 | 70 |
| 2018 October | 51 | 19 | 70 |
| 2018 September | 28 | 16 | 44 |
| 2018 August | 1 | 0 | 1 |
| 2018 July | 5 | 0 | 5 |
| 2018 June | 3 | 0 | 3 |
| 2018 May | 7 | 0 | 7 |
| 2018 April | 24 | 0 | 24 |
| 2018 March | 30 | 0 | 30 |
| 2018 February | 29 | 0 | 29 |
| 2018 January | 16 | 0 | 16 |
| 2017 December | 26 | 0 | 26 |
| 2017 November | 13 | 0 | 13 |
| 2017 October | 14 | 0 | 14 |
| 2017 September | 20 | 0 | 20 |
| 2017 August | 16 | 0 | 16 |
| 2017 July | 24 | 0 | 24 |
| 2017 June | 31 | 14 | 45 |
| 2017 May | 22 | 11 | 33 |
| 2017 April | 18 | 9 | 27 |
| 2017 March | 12 | 2 | 14 |
| 2017 February | 15 | 6 | 21 |
| 2017 January | 9 | 4 | 13 |
| 2016 December | 31 | 15 | 46 |
| 2016 November | 40 | 8 | 48 |
| 2016 October | 45 | 6 | 51 |
| 2016 September | 41 | 5 | 46 |
| 2016 August | 10 | 2 | 12 |
| 2016 July | 9 | 0 | 9 |
| 2016 February | 2 | 0 | 2 |
| 2015 December | 4 | 0 | 4 |
| 2015 September | 0 | 6 | 6 |
| 2015 August | 1 | 0 | 1 |
| 2015 July | 15 | 1 | 16 |
| 2015 June | 16 | 0 | 16 |
| 2015 May | 26 | 0 | 26 |
| 2015 April | 24 | 2 | 26 |
| 2015 March | 28 | 1 | 29 |
| 2015 February | 20 | 3 | 23 |
| 2015 January | 40 | 1 | 41 |
| 2014 December | 33 | 3 | 36 |
| 2014 November | 27 | 2 | 29 |
| 2014 October | 44 | 1 | 45 |
| 2014 September | 33 | 2 | 35 |
| 2014 August | 40 | 3 | 43 |
| 2014 July | 43 | 4 | 47 |
| 2014 June | 84 | 2 | 86 |
| 2014 May | 94 | 2 | 96 |
| 2014 April | 79 | 3 | 82 |
| 2014 March | 97 | 20 | 117 |
| 2014 February | 65 | 13 | 78 |
| 2014 January | 63 | 12 | 75 |
| 2013 December | 106 | 14 | 120 |
| 2013 November | 64 | 13 | 77 |
| 2013 October | 96 | 18 | 114 |
| 2013 September | 68 | 18 | 86 |
| 2013 August | 97 | 19 | 116 |
| 2013 July | 58 | 9 | 67 |
| 2013 June | 14 | 4 | 18 |
| 2013 May | 24 | 6 | 30 |
| 2013 April | 26 | 5 | 31 |
| 2013 March | 33 | 4 | 37 |
| 2013 February | 45 | 11 | 56 |
| 2013 January | 46 | 1 | 47 |
| 2012 December | 57 | 6 | 63 |
| 2012 November | 41 | 8 | 49 |
| 2012 October | 24 | 0 | 24 |
| 2012 September | 7 | 2 | 9 |
| 2012 August | 3 | 2 | 5 |
| 2005 May | 3357 | 0 | 3357 |
Show all
